ClinicalTrials.gg
Enrolling by invitationNCT07379853Updated Feb 3, 2026

Interactive E-Learning for Therapist Training in Exposure Therapy

An interventional study of Therapist Training in Therapist Training and ANXIETY DISORDERS (or Anxiety and Phobic Neuroses), sponsored by Bradley Hospital. Enrolling by invitation at 1 site in United States. Open to participants aged 21 Years to 99 Years. Per ClinicalTrials.gov, last updated 2026-02-03.

Primary conditionPhobic DisordersRegistry: Anxiety DisordersReclassifiedWhy we changed it
Registry
Anxiety Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Phobic Disorders
Why
  1. The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it.
  2. The study's listed conditions name Phobic Disorders, a narrower term within Anxiety Disorders.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by Bradley Hospital · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 9 months after the study started (first participant enrolled Apr 2025, registered Jan 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Not applicable
Ages
21 Years to 99 Years
Sex
All
01

Study summary

The project involves the development of an eLearning platform to train therapists in the delivery of exposure therapy for clients with anxiety disorders and OCD. Following initial development, clinician end users will complete rounds of iterative feedback to inform final development, at which point, therapists will be recruited to complete the entire training program in an open trial.

Read the detailed description

Despite the existence of numerous well-established evidence-based practices (EBPs) for mental disorders, it has been difficult to disseminate these practices in community settings. Exposure therapy for anxiety disorders represents one of the most glaring examples of this research-to- practice gap. Many practicing therapists have never had the opportunity to receive training in exposure therapy and cite this as a primary barrier to its delivery. To address this gap, investigators need to rethink the way in which they train providers. Recent advances in e-learning offer an exciting opportunity to automate both the didactic and interactive components of these evidence-based training modules-an approach that has potential to vastly improve scalability, thus addressing a primary barrier to accessing the most potent treatment available for anxiety. In this project, the team will develop and initially test an automated eLearning approach for therapists learning exposure therapy. The investigators will leverage evidence-based training content and strategies from their prior work, as well as recent advances in eLearning (e.g., adaptive eLearning). The proposed Phase I STTR study will take place in three stages. Stage one (Development) is a nine-month development period during which PARC Innovations will build an alpha version of the training program in accordance with specifications from the research team and early input from a Multi-perspective Advisory Panel (MAP). The MAP (N=8) will consist of professionals with expertise in commercialization, education \& e-learning, and/or technology. In Stage two (End- User Feedback and Optimization), a group of clinician end-users (N = 8) will interact with the platform and provide quantitative and qualitative feedback that will be synthesized by the research team into action items for further development. In stage three (Training Trial), therapists (N=40) will complete 8 hours of e-learning training (self-paced) over three weeks. Usability and training outcomes (e.g., therapist knowledge, self-efficacy) from this pilot trial will support a Phase II STTR project aimed at building out and broadly disseminating this eLearning approach.

02

Conditions studied

  • Therapist Training
  • ANXIETY DISORDERS (or Anxiety and Phobic Neuroses)

Browse trials for

Keywords

  • Therapist training
  • Exposure therapy
  • Anxiety Disorders
03

In context

Phobic Disorders Reclassified

84 studies on the registry are indexed under Phobic Disorders; 15 are open to participants now.

This study's planned enrollment of 56 is below the median of 66 across 69 interventional studies indexed under Phobic Disorders.

Browse Phobic Disorders studies →

Lead sponsor

Bradley Hospital is the lead sponsor of 22 studies on the registry; 8 are open to participants now.

Compared within Phobic Disorders, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

04

Who can participate

Ages eligible
21 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • A practicing therapist providing psychotherapy
  • Providing treatment for clients with anxiety conditions

Exclusion criteria

Exclusion Criteria:

- Not employed as a mental health provider

05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
56 participants (estimated)

Study arms

  • Experimental
    Open Training Trial

    Therapist will complete the entire eLearning training program

    Other: Therapist Training

Interventions

  • OtherTherapist Training

    Therapist training in Exposure Therapy delivery using an eLearning platform

06

What researchers measure

Primary outcomes

  1. Therapist Beliefs about Exposure (TBES)

    The TBES is a well-validated, 21-item likert measure of therapist reservations about exposure therapy delivery. Total scores range from 0-84 with higher scores representing more reservations about using exposure therapy with clients.

    Time frame: Immediately before initiating the training program and immediately after completing the 10-hour training intervention.

  2. System Usability Scale (SUS)

    The SUS is a well-validated measure of usability and acceptability of new innovations. This measure is especially common in the evaluation of new software systems. The measure consists of a 10-item measure on a 5-point likert scale. The scale is converted to a 0-100 score with higher scores indicating higher levels of perceived usability.

    Time frame: Immediately before starting the training program and immediately after completing the 10-hour training intervention

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Apr 2025 (actual). Primary completion is estimated for Mar 2027, 23 months after the start.

Of 28 interventional studies with no phase under Phobic Disorders, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 9 and three quarters within 44. This study's planned 23 months is below that.

How these figures are worked out, and which studies are left out of them.

Registered
Jan 22, 2026
First posted
Feb 2, 2026
StartActual
Apr 17, 2025
Primary completionEst.
Mar 31, 2027
CompletionEst.
Mar 31, 2027
Last update
Feb 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Feb 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07379853
Lead sponsor
Bradley Hospital
Responsible party
Sponsor
First posted
Feb 2, 2026
Start date
Apr 17, 2025
Primary completion
Mar 31, 2027 (estimated)
Completion
Mar 31, 2027 (estimated)
Last update
Feb 3, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

No contact was published for this record. The registry link below has the sponsor’s details.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion